# Comparative Efficacy of Rebamipide Gargle And Benzydamine HCL Gargle in Prevention and Management of Chemo- and Radio-therapy-induced Oral Mucositis

> **NCT04685395** · PHASE3 · UNKNOWN · sponsor: **Cairo University** · enrollment: 100 (actual)

## Conditions studied

- Oral Mucositis

## Interventions

- **DRUG:** Ribamipide gargle \benzdymine HCL gargel

## Key facts

- **NCT ID:** NCT04685395
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-26
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-09-15
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04685395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04685395, "Comparative Efficacy of Rebamipide Gargle And Benzydamine HCL Gargle in Prevention and Management of Chemo- and Radio-therapy-induced Oral Mucositis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04685395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*